سامانه کنگره های دانشگاه علوم پزشکی و خدمات بهداشتی و درمانی آذربایجان غربی

صفحه اصلی / بیستمین همایش سالیانه بیماری های شایع گوارش و کبد کودکان ایران و دومین همایش بین المللی چاقی کودکان

Pharmacological Interventions for Obesity in Children with Asymptomatic Fatty Liver Disease

نویسندگان :

Samaneh Sepahi¹ Sakineh Nouri Saeidlou² Mohammad Yousefi³

1- دانشگاه علوم پزشکی ارومیه 2- دانشگاه علوم پزشکی ارومیه 3- دانشگاه علوم پزشکی ارومیه

کلمات کلیدی :

Pediatric obesity،NAFLD،Pharmacotherapy،GLP-1 agonists،Weight management

چکیده :

Abstract Background and Aim: The growing issue of childhood obesity has been linked to a rise in non-alcoholic fatty liver disease (NAFLD). This condition often doesn’t show symptoms in its early stages, but it can progress to more serious issues like steatohepatitis (NASH) and cirrhosis. While obesity is the main modifiable risk factor, lifestyle changes alone often fall short in achieving lasting weight loss or improving liver health. This review looks into how pharmacological treatments can help manage obesity and slow down the progression of NAFLD in children. Methods: We conducted a narrative synthesis of literature from 2015 to 2024, utilizing databases like PubMed, Cochrane, and Scopus. Our focus was on randomized controlled trials (RCTs), meta-analyses, and guidelines that discuss FDA/EMA-approved or investigational drugs (such as orlistat, liraglutide, and metformin) for treating obesity in children aged 6 to 18 with NAFLD. We gathered data on effectiveness (like BMI reduction, liver enzyme levels, and imaging/histology) and safety. Results: Orlistat, which works as a lipase inhibitor, resulted in modest BMI reductions of about 2-3%, but it offered limited benefits for the liver and often caused gastrointestinal side effects. On the other hand, GLP-1 agonists, like liraglutide, showed better results, with trials indicating a 5-10% reduction in BMI and improvements in ALT levels and steatosis scores for some patients. Metformin produced mixed outcomes, while newer treatments like SGLT-2 inhibitors have shown promise in adult studies but lack solid evidence for children. Combination therapies, such as phentermine/topiramate, are still not well-studied in pediatric populations. Conclusion: Pharmacological treatments, especially GLP-1 agonists, could be a valuable addition to lifestyle changes for obese children dealing with NAFLD, although we still need more data on their long-term safety and effectiveness. It’s crucial to create personalized treatment plans and have multidisciplinary monitoring in place. Future RCTs should focus on protocols tailored for children and include histological endpoints.

لیست مقالات

لیست مقالات بایگانی شده

The effectiveness of group training based on the Bakroid method on improving eating attitudes and increasing self-esteem in obese adolescent girls

Fateme Mohammadi - Ghazaleh Orouji - Kowsar Soltani - Khadijh Mohammadi - Zahra Mohammadi

Title: "Addressing Childhood Obesity: A Comprehensive Review of Interventions, Policies, and Emerging Trends

Maryam Maghsoodlo

A review of management and treatment of Inflammatory Bowel Diseases in children: challenges, novel approaches, and future research directions

Haniye Karimipour - Elahe Karimipour

Gut Microbiome and Pediatric Obesity :A Review

Aylin Ebrahimpour - Faezeh Ghalichi - Negar Moosaee Farahani

Optimizing Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients: A Systematic Review and Meta-Analysis

Yousef Tavakolifar - Aydin Mahmoud Alilou - Parinaz Mahmoud Alilou - Amir Hossein Eskandari - Amir Reza Bana Nasli - Asal Khaksar Kolvanagh - Alisan Khodayarlo - Sina Manouchehrnia - Pouria Shieeh - Sana Nasirpour - Meysam Najafi - Reza Rostami - Pardis Pour Ali

Obesity as a possible risk factor for the occurrence of pilonidal cyst disease in children

Sina Karimipour - Babak Sabet

Non-Alcoholic Fatty Liver Disease in Children: An Epidemiological Snapshot and Regional Considerations in Urmia, Iran

Adviya Ali - Saliha Muzaffer - Muhamed Rzgar

Phenylketonuria and Pediatric Obesity: A Comprehensive Systematic Review and Meta-Analysis

Sadra Khodaei Alamdari - Sajjad Moradi - Aylin Ebrahimpour

A Review of the Impact of Lifestyle on the Increase of Functional Gastrointestinal Disorders in Children

Elahe Karimipour - Haniye Karimipour

The association of gut microbiota in obese children with non-alcoholic fatty liver disease: A Review

Aylin Ebrahimpour - Faezeh Ghalichi - Sadra Khodaei Alamdari

بیشتر

ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.4.2